HMOX1 and gestational diabetes: This finding corresponds to the observation from our flexible dose response model (i.e., from GAM models) and related splines (Figure 2), where we noted an inverse association of GDM risk with increasing HO-1 concentrations, particularly when concentrations exceeded 3 ng/mL (Figure 2).